Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine besylate + losartan potassium tablets ABPM efficacy and safety in primary mild to moderate hypertension
CTR20170140Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine besylate + losartan potassium in essential hypertension, sponsored by Hanmi Pharmaceutical. Started Mar 2017; status: completed.
02
Drugs
amlodipine besylate + losartan potassium
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20170140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170140.